Skybiotech Healthcare Limited reported a consolidated net loss of ₹111.68 lakh for the financial year ended March 31, 2026, narrowing from a loss of ₹236.89 lakh in the previous year. The company's board approved the audited financial results for the quarter and year ended March 31, 2026, at a meeting held on May 30, 2026. The statutory auditor, SPD & Associates, issued an unmodified opinion on the standalone and consolidated financial results.

Consolidated Financial Performance

For the year ended March 31, 2026, the company reported total income of ₹740.38 lakh, a slight decrease from ₹743.45 lakh in FY25. Total expenses for the period stood at ₹907.04 lakh, down from ₹986.00 lakh in the previous year. The profit before tax for the year was a loss of ₹166.66 lakh, compared to a loss of ₹242.55 lakh in FY25.

Standalone Results

On a standalone basis, the company reported a net loss of ₹6.03 lakh for FY26, compared to a net profit of ₹5.96 lakh in the previous year. Total income for the year stood at ₹6.69 lakh, significantly lower than the ₹18.12 lakh reported in FY25. Total expenses increased to ₹12.69 lakh from ₹10.53 lakh in the prior year.

The board also reviewed the limited review report for the quarter and took on record the audit report issued by the statutory auditors. The meeting was conducted in compliance with Regulation 30 of the SEBI (LODR) Regulations, 2015.

Skybiotech Healthcare Limited has filed its quarterly compliance certificate with BSE Limited for the quarter ended 31st March, 2026, in accordance with SEBI (Depositories and Participants) Regulations, 2018. The company, formerly known as Kapil Cotex Limited, submitted the mandatory documentation on 09th April, 2026.

Regulatory Compliance Certificate

The certificate was issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, which requires companies to report on the dematerialization of physical share certificates. Satellite Corporate Services Pvt. Ltd., serving as the company's Registrar and Share Transfer Agent, provided the compliance certificate dated 06th April, 2026.

Dematerialization Status

The certificate confirms that no physical share certificates were received for dematerialization during the quarter ended 31st March, 2026. This indicates that all existing shares of the company remain in their current form without any conversion from physical to electronic format during the reporting period.

Satellite Corporate Services Pvt. Ltd., a Category-I Registrar with registration number INR000003639, certified that the standard verification processes for dematerialization were maintained, though no physical certificates required processing during Q4 FY26.

Company Information

Skybiotech Healthcare Limited operates under CIN L21001MH1983PLC031114 with its registered office located at Gut No. 05, Gevrai Tanda, Paithan Road, Chh. Sambhaji Nagar (Aurangabad), Maharashtra. The filing was signed by Managing Director Poonam Prakash Rathi (DIN: 01274428), ensuring proper authorization of the regulatory submission.

This compliance filing represents the company's ongoing commitment to meeting SEBI's regulatory requirements for listed entities and maintaining transparency in share transfer operations.